Mithrl

AI co-scientist for drug discovery

Mithrl is building the first commercially available AI co-scientist, a discovery engine that turns messy biological data into insight in minutes. Scientists ask questions in natural language and receive real analysis, novel targets, hypotheses and patent-ready reports — the patent-ready output being the tell that it produces work product rather than suggestions. The company reports 12x year-over-year revenue growth and is trusted by leading biotechs and large pharmaceutical companies across three continents, driving results from target discovery through to patient outcomes.